This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, F. Articles by McKeehan, W. L. Search for Related Content PubMed PubMed Citation Articles by Wang, F. Articles by McKeehan, W. L.

Fibroblast Growth Factor Receptor 1 Phosphotyrosine 766

Molecular Target for Prevention of Progression of Prostate Tumors to Malignancy¹

Department of Biochemistry and Biophysics, Texas A&M University [W. L. M.], and Center for Cancer Biology and Nutrition, Institute of Biosciences and Technology, Texas A&M University System Health Science Center [F. W., K. M., C. Y.], Houston, Texas 77030-3303

Dissection of processes that promote the slow progression to malignancyfrom those that drive the malignant phenotype, once acquired, is important for identification of molecular targets for rational design of dietary and pharmaceutical intervention to hold premalignant cancer in check. In adult parenchymal organs, fibroblast growth factor receptor (FGFR) kinase isotypes are partitioned between stroma and epithelium, respectively, and mediate communication between the two compartments to maintain organ homeostasis. The ectopic appearance of stromal FGFR1 is a hallmark of epithelial cells from model transplantable rat prostate tumors that progress to malignancy. Here we show that, despite the fact that it is transcriptionally active, the appearance of FGFR1 in nonmalignant prostate tumor epithelial cells at first does not drive cell proliferation or support a malignant phenotype. These properties develop over time with proliferative aging of the cell population coincident with FGFR1-dependent activation of the mitogen-activated protein kinase signaling pathway. Phospholipase C-interactive phosphotyrosine 766 of FGFR1 is required for the age-dependent acquisition of the proliferative response to FGFR1, although it appears not to be required for the mitogenic response. Although of little utility in late-stage therapy, this suggests that pathways linked to FGFR1 tyrosine 766 may be specific targets for prevention of progression of latent nonmalignant tumors to the life-threatening malignant state.

This article has been cited by other articles:

				Y. Zhang, J. Zhang, Y. Lin, Y. Lan, C. Lin, J. W. Xuan, M. M. Shen, W. L. McKeehan, N. M. Greenberg, and F. Wang Role of epithelial cell fibroblast growth factor receptor substrate 2{alpha} in prostate development, regeneration and tumorigenesis Development, February 15, 2008; 135(4): 775 - 784. [Abstract] [Full Text] [PDF]

				Y. Zhang, K. McKeehan, Y. Lin, J. Zhang, and F. Wang Fibroblast Growth Factor Receptor 1 (FGFR1) Tyrosine Phosphorylation Regulates Binding of FGFR Substrate 2{alpha} (FRS2{alpha}) But Not FRS2 to the Receptor Mol. Endocrinol., January 1, 2008; 22(1): 167 - 175. [Abstract] [Full Text] [PDF]

				Y. Zhang, Y. Lin, C. Bowles, and F. Wang Direct Cell Cycle Regulation by the Fibroblast Growth Factor Receptor (FGFR) Kinase through Phosphorylation-dependent Release of Cks1 from FGFR Substrate 2 J. Biol. Chem., December 31, 2004; 279(53): 55348 - 55354. [Abstract] [Full Text] [PDF]

				B Kwabi-Addo, M Ozen, and M Ittmann The role of fibroblast growth factors and their receptors in prostate cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 709 - 724. [Abstract] [Full Text] [PDF]

				C. Jin, F. Wang, X. Wu, C. Yu, Y. Luo, and W. L. McKeehan Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors Cancer Res., July 1, 2004; 64(13): 4555 - 4562. [Abstract] [Full Text] [PDF]

				C. Jin, K. McKeehan, W. Guo, S. Jauma, M. M. Ittmann, B. Foster, N. M. Greenberg, W. L. McKeehan, and F. Wang Cooperation between Ectopic FGFR1 and Depression of FGFR2 in Induction of Prostatic Intraepithelial Neoplasia in the Mouse Prostate Cancer Res., December 15, 2003; 63(24): 8784 - 8790. [Abstract] [Full Text] [PDF]

				X. Wu, C. Jin, F. Wang, C. Yu, and W. L. McKeehan Stromal Cell Heterogeneity in Fibroblast Growth Factor-mediated Stromal-Epithelial Cell Cross-Talk in Premalignant Prostate Tumors Cancer Res., August 15, 2003; 63(16): 4936 - 4944. [Abstract] [Full Text] [PDF]